GALAPAGOS (GLPG.AS) Financials

GLPG.AS Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 4.5 billion 1.8 billion
2023-06-30 4.5 billion 1.9 billion
2023-03-31 4.6 billion 2.1 billion
2022-12-31 4.7 billion 2.2 billion

GLPG.AS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -122.0 million ?
2023-06-30 -129.2 million ?
2023-03-31 -99.2 million ?
2022-12-31 -187.7 million 37.4 million

GLPG.AS Net Income

No data available :(

GLPG.AS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 - - 14.1 million
2023-06-30 - - 15.4 million
2023-03-31 - - 16.0 million
2022-12-31 - - 21.9 million

GLPG.AS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 65.9 million
2023-06-30 65.9 million
2023-03-31 65.9 million
2022-12-31 65.8 million

GLPG.AS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 3.2 million 100.3 million 84.7 million -
2023-06-30 3.8 million 108.4 million 39.4 million -
2023-03-31 4.3 million 103.5 million 58.1 million -
2022-12-31 7.6 million 151.0 million 74.7 million -

GLPG.AS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 120.0 million 5.7 million
2023-06-30 150.0 million 4.3 million
2023-03-31 178.9 million 3.6 million
2022-12-31 95.1 million 4.1 million

GLPG.AS

Price: €26.78

52 week price:
26.56
41.92

Earnings Per Share: -0.06 EUR

P/E Ratio: -15.65

Exchange: AMS

Sector: Healthcare

Industry: Biotechnology

Volume: 141215

Market Capitalization: 1.8 billion

Links: